Papillary serous carcinoma of the ovary following prolonged tamoxifen treatment.
We present a patient with breast cancer who developed papillary serous adenocarcinoma of the ovary after 13 years of tamoxifen use. The possible association is explored and the literature is reviewed.
Department of Obstetrics and Gynecology, American University of Beirut Medical Center, Lebanon.
M
M
Seoud
Z
Z
Salem
A
A
Shamseddine
A
A
Khabbaz
G
G
Zaatari
A
A
Khalil
D000368:Aged; D001943:Breast Neoplasms / Q000188:drug therapy*; D018283:Cystadenocarcinoma, Papillary / Q000139:chemically induced*; D004965:Estrogen Antagonists / Q000009:adverse effects*; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000139:chemically induced*; D013629:Tamoxifen / Q000009:adverse effects*
D004965:Estrogen Antagonists; D013629:Tamoxifen